And Then There Were Six…FDA Green Lights Hugel’s Toxin for Glabellar Lines
The U.S. Food and Drug Administration (FDA) has given its nod to Letybo (foletibotulinumtoxinA) for the treatment of moderate-to-severe glabellar lines in adults. Now, there are six neuromodulators approved for cosmetic use in the U.S.: Botox Cosmetic (Allergan), Dysport (Galderma), Jeuveau (Evolus), Xeomin (Merz Aesthetic), Daxxify (Revance), and Letybo (Hugel). Hugel plans to accelerate its […]